Metraipolis › archive › dc_6d4fdb583bba

Safety of ozanimod and etrasimod in ulcerative colitis: A disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System… — Europe PMC PMID:42629668

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42629668
DOI
10.1097/md.0000000000050262
License (as archived)
solo-consultazione
Archived
2026-10-07T17:21:46.694Z
SHA-256 of the archived text
19b31e14997a260a86536ff8cbfacd80ea487fcce138615bed2d6d7356592171
Stable URL of this page
https://metraipolis.com/documento/dc_6d4fdb583bba

How to cite

Safety of ozanimod and etrasimod in ulcerative colitis: A disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System… — Europe PMC PMID:42629668 — Europe PMC (en), https://europepmc.org/article/MED/42629668 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6d4fdb583bba (Metraipolis archive dc_6d4fdb583bba, sha256 19b31e14997a260a86536ff8cbfacd80ea487fcce138615bed2d6d7356592171)
BibTeX
@misc{dc6d4fdb583bba,
  title = {Safety of ozanimod and etrasimod in ulcerative colitis: A disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System… — Europe PMC PMID:42629668},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42629668},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6d4fdb583bba; sha256 19b31e14997a260a86536ff8cbfacd80ea487fcce138615bed2d6d7356592171},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42629668. Agents can read the archived copy with the MCP tool read_document.